Pei Zhang

Pei Zhang obtained her PhD degree in Pharmaceutical Analysis in 2017 from China Pharmaceutical University (Nanjing, China). In her thesis, she applied mass spectrometry-based metabolomics to study the mechanism and personalization of cisplatin-induced nephrotoxicity. She joined the Wheelock Lab in November 2017. Her work is focused on the use of mass spectrometry-based approaches to examine the relationship between early childhood exposure to environmental chemicals of concern and onset of disease.